ROS1 and lung cancer: ROS1-rearranged primary lung cancer should be treated with an ROS1 inhibitor because of its proven efficacy; however, the efficacy of ROS1 inhibitors for ROS1-rearranged putative lung adenocarcinoma is uncertain.